Skip to main content

FDA Listing Inc.

FDA Listing Logo

FDA LISTING INC: EXPERIENCED ADVISORS FOR FULL-SERVICE FDA REGISTRATION & COMPLIANCE

+1 212 444 8202

U.S. FDA Registration

& Labeling Compliance Assistance

FDA Sunscreen Monograph M020

FDA Sunscreen Monograph M020 outlines conditions that may apply to over-the-counter sunscreen drug products marketed in the United States, including permitted active ingredients, concentration limits, labeling, testing, and related compliance requirements.

OTC Monograph M020: Sunscreen Drug Products

Sunscreen products marketed with SPF, sun-protection, broad-spectrum, or water-resistance claims are generally regulated as OTC drug products in the United States. FDA Monograph M020 covers many topical sunscreen dosage forms, including lotions, creams, sticks, sprays, gels, and oils.

 

For brand owners, importers, private-label companies, and manufacturers, key compliance considerations include permitted UV active ingredients and concentrations, SPF and broad-spectrum claims, applicable testing, Drug Facts labeling, and FDA drug establishment registration and drug-listing requirements.

Sunscreen Product Categories

FDA Monograph M020 may apply to sunscreen lotions, creams, gels, sticks, balms, sprays, oils, mineral sunscreen products, facial sunscreens, daily moisturizers with SPF, broad-spectrum products, water-resistant products, children’s sunscreens, and sport sunscreens.

 

The product format alone does not determine whether a product fits the monograph. Also review the active ingredients, their concentration, the finished product’s SPF claim, supporting testing, dosage form, directions for use, and labeling.

Common Sunscreen Active Ingredients

Below is the reference schedule of recognized active ingredients, maximum permitted concentration levels, and standard product designations under FDA OTC Monograph M020:

Active IngredientMaximum ConcentrationCommon Product Terms
Zinc oxideUp to 25%Mineral sunscreen, zinc sunscreen, sensitive-skin sunscreen
Titanium dioxideUp to 25%Mineral sunscreen, physical sunscreen, SPF cream
AvobenzoneUp to 3%Broad-spectrum sunscreen, chemical sunscreen
BemotrizinolUp to 6%Broad-spectrum sunscreen, UVA/UVB sunscreen
OctocryleneUp to 10%Broad-spectrum sunscreen, sunscreen lotion
OctisalateUp to 5%SPF lotion, daily facial sunscreen
HomosalateUp to 15%Sunscreen lotion, body sunscreen
OctinoxateUp to 7.5%Facial sunscreen, chemical sunscreen
OxybenzoneUp to 6%Broad-spectrum sunscreen, UV-filter product
EnsulizoleUp to 4%Lightweight sunscreen, facial SPF product
FDA issued Final Administrative Order OTC000039 to amend OTC Monograph M020 and add bemotrizinol as a permitted sunscreen active ingredient. Under the order, bemotrizinol may be used at concentrations up to 6%, subject to applicable conditions for combination, dosage form, and testing.

Key Sunscreen Labeling Points

Review sunscreen labeling as part of the finished product’s overall compliance position. Claims, active ingredients, testing records, product format, Drug Facts content, principal display panel statements, and online marketing should align with the product’s applicable conditions.

SPF Claims

The SPF value displayed on a sunscreen label should be supported by applicable SPF testing of the finished product. The stated SPF, product dosage form, directions for use, Drug Facts content, and related marketing materials should match the product tested.

 

For example, a brand should not use an SPF 50 claim for a reformulated product solely because an earlier formula was tested as SPF 50. Material changes to active ingredients, concentration, vehicle, or product format may affect the compliance assessment.

Broad-Spectrum Claims

“Broad Spectrum SPF” claims require applicable broad-spectrum testing. A sunscreen that does not meet the required broad-spectrum test should not be labeled or promoted as broad-spectrum.

 

Broad-spectrum labeling relates to protection across both UVA and UVB wavelengths. The claim should appear consistently across the principal display panel, Drug Facts label, product packaging, website copy, retailer listings, and advertising.

Water-Resistance Claims

Support a water-resistance claim with applicable testing of the finished product. When the conditions for the claim are met, sunscreen labeling may state “Water Resistant (40 minutes)” or “Water Resistant (80 minutes),” as applicable. The time statement should reflect the test-supported duration and should be presented consistently on packaging, the Drug Facts panel, ecommerce listings, website copy, and promotional materials. Do not use terms such as “waterproof” or “sweatproof” in place of a compliant water-resistance claim.

Drug Facts Labeling

Sunscreen products should include appropriate Drug Facts information, including active ingredients, purpose, uses, warnings, directions, and inactive ingredients. The Drug Facts panel should correspond to the finished product that is commercially distributed.

 

Review front-label statements, product name, SPF number, broad-spectrum claims, water-resistance claims, website content, retailer product descriptions, and advertising for consistency with the Drug Facts panel. For products that pass the applicable broad-spectrum test, FDA labeling requirements specify the statement “Broad Spectrum SPF [value]” on the principal display panel.

FDA Monograph Information

This page provides a simplified overview of FDA OTC Monograph M020. It does not include every ingredient condition, dosage-form requirement, testing requirement, labeling detail, or FDA administrative order that may apply to a specific sunscreen product.

 

For complete and current requirements, including active-ingredient conditions and administrative orders applicable to OTC sunscreen drug products, review the related official FDA monograph resource.

FDA Sunscreen Compliance Services

Sunscreen compliance involves more than selecting UV filters. A product review may include active ingredients, concentration levels, SPF claims, broad-spectrum and water-resistance claims, Drug Facts labeling, manufacturing activities, and drug-listing information.

We assist with:

  • Drug Establishment Registration
  • OTC Drug Listing
  • NDC Labeler Code
  • OTC Drug Label Review
  • Drug Master File
Need help with an FDA-regulated sunscreen product? Our team can assist with Drug Establishment Registration, OTC Drug Listing, NDC Labeler Codes, OTC Drug Label Review, and Drug Master Files.

Frequently Asked Questions (FAQ)

Sunscreen products marketed with SPF, sun-protection, broad-spectrum, or water-resistance claims are generally regulated as OTC drug products in the United States. This may include otherwise cosmetic products, such as moisturizers or facial creams, when they make drug-type sunscreen claims.
FDA Monograph M020, Sunscreen Drug Products for Over-the-Counter Human Use, establishes conditions that may apply to OTC sunscreen drug products. These conditions include permitted active ingredients, concentration limits, product forms, testing, labeling, and claim requirements.
An OTC sunscreen that conforms to the applicable conditions of Monograph M020 does not require individual FDA premarket approval like a drug marketed under an approved new drug application. However, the product must meet all applicable monograph, labeling, testing, manufacturing, registration, and listing requirements before commercial distribution.
A sunscreen may use “Broad Spectrum SPF” labeling only when the finished product passes the applicable FDA broad-spectrum test for UVA and UVB protection. The SPF value must also be supported by testing of the finished product.
No. Sunscreen products should not be labeled “waterproof” or “sweatproof.” A product may make a water-resistance claim only when supported by applicable testing, with labeling that states whether the product maintains its SPF protection for 40 or 80 minutes while swimming or sweating.
Generally, OTC sunscreen drug products require a Drug Facts panel. The panel includes information such as active ingredients, purpose, uses, warnings, directions, and inactive ingredients. OTC sunscreen products are also subject to applicable general OTC-drug labeling requirements.
FDA drug establishment registration and drug listing may apply to the entities responsible for manufacturing, processing, packing, repacking, or relabeling an OTC sunscreen drug product for commercial distribution. Domestic and foreign manufacturers, repackers, and relabelers generally must register and list applicable commercially marketed drug products. Listing is submitted electronically in Structured Product Labeling, or SPL, format, and the proper listing arrangement can vary depending on whether the product is manufactured for a private-label distributor or through a contract manufacturer.

_______ Related Services _______